Cegedim (ALCGM.PA) Osake Kurssi
Cegedim Kurssi
Viimeisten 19 vuoden aikana Cegedimn liikevaihto kasvoi 1,0 % vuodessa ja ylsi 649,17 M EUR:een. Osakekohtainen tulos on laskenut 7,2 % vuodessa viimeisten 19 vuoden aikana. Cegedimn nettomarginaali 1,4 % on laskenut verrattuna 5,0 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 4,63 %. Jakosuhde on noin 50 % tuloksesta. Cegedimn 12 kuukauden konsensustavoitehinta on 13,26 EUR, noin yli kurssia 22,8 %. 9 analyytikosta 0 suosittaa ostoa — kokonaiskonsensus on Myy.
Cegedim osakekurssi
Cegedim liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Cegedim -osakkeesta
Cegedim SA is a global technology and services company serving the healthcare industry. Its business model revolves around providing innovative solutions and services to healthcare professionals, pharmaceutical companies, and other stakeholders. Cegedim SA offers a wide range of products, including patient data management systems, electronic health records, pharmacy management software, and marketing solutions. Through its comprehensive portfolio, Cegedim SA enables better patient care, drives operational efficiency, and facilitates collaboration within the healthcare ecosystem. With years of expertise and a strong focus on technology-driven solutions, Cegedim SA continues to play a crucial role in transforming and improving healthcare worldwide.
Cegedim SA is primarily active in the healthcare and technology industries.
The main competitors of Cegedim SA in the market include IBM, Cerner Corporation, and Allscripts Healthcare Solutions.
Cegedim SA, a leading technology and services company, has a rich history and background. Established in 1969, Cegedim initially focused on providing innovative software solutions for healthcare professionals. Over the years, it expanded its offerings to pharmaceutical companies, insurance providers, and other healthcare stakeholders. Today, Cegedim is a global organization, operating in over 70 countries and serving more than 420,000 users. The company's strong commitment to research and development has allowed it to stay at the forefront of digital transformation in the healthcare industry. Cegedim SA's expertise and comprehensive portfolio make it a trusted partner for businesses seeking innovative and efficient healthcare solutions.
Cegedim SA, a renowned company, has achieved several significant milestones throughout its existence. It has successfully positioned itself as a global leader in innovative technology and services for the healthcare industry. Over the years, Cegedim SA has shown exceptional growth and development, expanding its presence across multiple continents. The company has established fruitful partnerships with key industry players and consistently delivers cutting-edge solutions to optimize healthcare practices. Cegedim SA's dedication to excellence and commitment to meeting evolving market demands have propelled them to become a trusted and respected name in the healthcare sector.
Cegedim SA is primarily present in various countries and regions worldwide. With its headquarters in France, the company has established a strong presence in Europe, particularly in countries like Germany, Italy, Spain, and the United Kingdom. Additionally, Cegedim SA operates in North America, with a significant presence in the United States and Canada. Furthermore, the company has expanded its reach to other regions, including Asia Pacific and Latin America. This global presence allows Cegedim SA to cater to a diverse range of clients and leverage its expertise in healthcare and technology solutions on an international scale.
Cegedim SA represents a set of core values and a strong corporate philosophy. The company is committed to excellence, innovation, and client satisfaction. With a focus on technological advancements and healthcare solutions, Cegedim SA strives to provide cutting-edge products and services. They prioritize integrity, transparency, and collaboration, aiming to build strong, trust-based relationships with their clients and partners. Cegedim SA's dedication to continuous improvement and customer-centricity drives their success in the dynamic stock market. This French-based company's values and philosophy define their approach to business and reinforce their position as a leading player in the industry.
Analyytikot asettavat tällä hetkellä Cegedim-osakkeelle keskimääräisen tavoitehinnan 12,92 EUR (mediaani: 13,26 EUR), mikä merkitsee +19,6 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.
9 analyytikkoa arvioi tällä hetkellä Cegedim-osaketta: 0 suosittaa ostoa, 5 pitoa ja 4 myyntiä. Vuodelle 2026 analyytikot odottavat Cegedim-yhtiöltä 660,10 M EUR liikevaihtoa ja 1,21 EUR osakekohtaista tulosta.
Cegedim-osake (ALCGM.PA) on listattuna 7 pörssissä, muun muassa: London (0DYQ.L), Frankfurt (C7E.F), München (C7E.MU), Düsseldorf (C7E.DU), Paris (CGM.PA).
Cegedim SA is a leading company in the healthcare industry that offers innovative technologies and services for medical record management, insurance claims processing, and the pharmaceutical industry. The company operates in various sectors, including Cegedim Health Data, Cegedim e-business, Cegedim Insurance Solutions, and Cegedim Strategic Data. Cegedim Health Data provides specialized solutions for managing medical patient data and interoperability within the healthcare industry. Cegedim e-business offers electronic transaction services and software platforms for businesses in the healthcare industry. Cegedim Insurance Solutions provides high-quality IT services for the health and accident insurance industry. Cegedim Strategic Data specializes in collecting and processing market data for the pharmaceutical and healthcare industries. In addition to these business sectors, Cegedim SA also offers specialized products and solutions. Their business model is focused on supporting healthcare industry customers to work efficiently and effectively by providing them with technology and data solutions.
odotettu liikevaihto Cegedim on 660,10 M EUR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Cegedim on 16,64 M EUR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Cegedim:n hinta-voitto-suhde (P/E) on tällä hetkellä 8,94. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Cegedim-osakkeen arvostusta.
Cegedim:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,23. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Cegedim-osakkeen arvostuskennuslukuna.
Cegedim:n Eulpool-laatuscore on 2/10.
Cegedim:n ISIN on FR0000053506. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Cegedim:n WKN on 895036. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Cegedim:n ticker on ALCGM.PA. Tämä pörssinoteeraus käytetään Cegedim-osakkeiden kauppaan pörssissä.
Cegedim osake
Cegedim vertaisryhmä
Cegedim Ticker
Cegedim FIGI
Kaikki tunnusluvut ja syvällinen analyysi Cegedim:sta
Meidän osakeanalyysimme Cegedim-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Cegedim:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: